Este sitio web utiliza tecnologías de seguimiento, como cookies, para brindar una mejor experiencia al usuario. Si continúa utilizando este sitio, entonces reconoce nuestro uso de tecnologías de seguimiento. Para obtener información adicional, consulte nuestra Política de Privacidad.
When Science magazine named cancer immunotherapy the 2013 “Breakthrough of the Year” last December, we knew that it was not only an affirmation of what we have been dedicated to for more than six decades, but that it would be the beginning of an exciting new era in cancer treatment. This past year served as a testament of the accelerated progress being made in the field of cancer immunotherapy research, which would not be possible without the accomplishments here at the Cancer Research Institute.
Some highlights from this year include:
Learn more about our programs and the advancements we’ve made this year.
View our 2014 Annual Report
Inmunoterapia vs. Quimioterapia: ¿Cual es la diferencia?
Read Next Article
*Los resultados de la inmunoterapia pueden variar de un paciente a otro.
Comuníquese con nosotros
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Directorio de Personal
Help us cheer on our Team CRI members who have been not only training for a marathon, but also helping to raise funds for a future immune to cancer.
This October for Liver Cancer Awareness Month, let’s delve into new treatments, research insights, and how we are fueling a future immune to liver cancer.